Who backs Solu Therapeutics?
11 investors| Investor | Type |
|---|---|
| Alexandria Venture Investments | Other |
| DCVC Bio | Venture capital |
| Astellas Venture Management | Other |
| Biovision Ventures | — |
| Eli Lilly | — |
| Hengdian Group Capital (HgC) | — |
| Leukemia & Lymphoma Society | — |
| Longwood Fund | — |
| Pappas Capital | — |
| Santé Ventures | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Solu Therapeutics
- ·The full record, as it builds
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Solu Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.